The increasing incidence of infectious diseases around the world is driving the global “infectious disease molecular diagnostics market Share”, says Fortune Business Insights, in a report, titled “Infectious Disease Molecular Diagnostics Market Size, Share and Global Trend By Technology (Mass Spectroscopy, Capillary Electrophoresis, Next Generation Sequencing, Chips & Microarrays, In-Situ Hybridization), By Disease Indication (Hepatitis, Human Immunodeficiency Virus (HIV) Infection, Human Papillomavirus (HPV) Infection), By End User (Hospitals & Clinics, Diagnostic Centres, Research Institutes) and Geography Forecast till 2026.” Rising awareness regarding prevention and early diagnosis of sexually transmitted diseases is expected to aid the growth of the global infectious disease molecular diagnostics market.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/infectious-disease-molecular-diagnostics-market-101146
Rising Prevalence of Infectious Diseases Will Propel Growth
A molecular diagnostic is an effective tool for the detection of HIV, HPV, and other infectious diseases. The increasing demand for molecular diagnostics is likely to boost the global infectious disease molecular diagnostics market revenue during the forecast period. Government support to tackle the rising cases of infectious diseases is predicted to further augment the growth of the global infectious disease molecular diagnostics market. The acquisitions and collaborations between key companies are also expected to contribute positively to the global infectious disease molecular diagnostics growth.
For instance, Bruker Corporation announced the acquisition of Hain Lifescience GmbH, an infectious disease molecular diagnostics company, to expand its footprint in molecular diagnostics. The launch of new molecular diagnostics platforms or instruments is likely to enable growth of the global infectious disease molecular diagnostics market. For instance, Qiagen announced the launch of QIAscreen HPV PCR Test, an in-vitro molecular diagnostics test for the detection of human papillomavirus in Europe Furthermore, the increasing prevalence of infectious diseases along with the rising awareness and shift towards personalized medicines and preventive care is expected to contribute to the global infectious disease diagnostic techniques shares. In 2017, According to the World Health Organization (WHO) there were approximately 36.9 million individuals diagnosed with HIV with an estimate of 1.8 million people diagnosed every year. These trends and factors together are predicted to uplift the infectious disease molecular diagnostics market shares in the forthcoming year.
Some of the Main Key Players Covered in the Infectious Disease Molecular Diagnostics Market Report:
- Dickinson and Company
- bioMérieux SA
- Hologic Inc.
- Myriad Genetics
- Thermo Fisher Scientific
Nonetheless, high installation and infrastructure cost of Molecular diagnostics is likely to hinder the growth of the global disease molecular diagnostics market. In addition, lack of skilled labour in developing countries is expected to further restrict the growth of the global infectious disease molecular diagnostics market.
Key Segmentation of Infectious Disease Molecular Diagnostics Market:
Infectious Disease Molecular Diagnostics Market Segments by Technology
- Mass Spectroscopy
- Capillary Electrophoresis
- Next Generation Sequencing (NGS)
- Chips & Microarrays
- In-Situ Hybridization (ISH)
Infectious Disease Molecular Diagnostics Market Segments by Disease Indication
- Human Immunodeficiency Virus (HIV) Infection
- Human Papillomavirus (HPV) Infection
By End User
- Hospitals & Clinics
- Diagnostic Centres
- Research Institutes
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Active Government Support Will Aid Growth in the Asia Pacific
Geographically, the global infectious disease molecular diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the global infectious disease molecular diagnostics market during the forecast period owing to the increasing prevalence of infectious diseases such as HIV and respiratory diseases. Established healthcare system and increasing R&D investment is also expected to enable the growth of the global infectious disease molecular diagnostics market.
The global infectious disease molecular diagnostics market in Asia Pacific is predicted to grow at a significant rate during the forecast period due to the active government support and improving access to the advanced diagnostic facility. In addition, the rapid adoption of preventive care will also boost the infectious disease molecular diagnostics market in Asia Pacific.
Some of the major companies that are present in the global infectious disease molecular diagnostics market are Abbott, Becton, Dickinson and Company, QIAGEN, Cepheid, bioMérieux SA, Hologic Inc., Myriad Genetics and Thermo Fisher Scientific.
More Trending Topics from Fortune Business Insights:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245